GlassScriptPhysician profile
James M Brooks
NPI 1861644429
$1,454.63
in general payments reported to CMS, 2019-2025
14 companies · $957 in 2025
The $957 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $68.47 · 2023: $106 · 2024: $135 · 2025: $957.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $344.63 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $341.52 | 2023-2025 | Afx2 Bifurcated Endograft System, Torus Stent Graft System, Endocross Device |
| Bayer Healthcare Pharmaceuticals INC. | $121.60 | 2025 | |
| Inari Medical, INC. | $106.31 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $105.24 | 2023-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Glaxosmithkline, LLC. | $94.83 | 2021-2022 | |
| Novo Nordisk INC | $74.27 | 2021 | |
| Silk Road Medical, INC. | $67.14 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $46.54 | 2021 | |
| Abbott Laboratories | $44.63 | 2022-2023 | Jeti |
| Neuros Medical, INC. | $35.83 | 2025 | Altius |
| Boston Scientific Corporation | $31.16 | 2023-2025 | Watchman Flx, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $21.42 | 2021 | |
| Medtronic, INC. | $19.51 | 2025 | In.Pact Admiral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.